Professor Dawn Langdon

Dawn Langdon completed her training as a clinical psychologist at Oxford University and King’s, London. She worked at Queen Square for many years, obtaining a PhD on Reasoning in Organic Brain Disease from the Institute of Neurology and registration as a health psychologist and a neuropsychologist. She is now Professor of Neuropsychology at Royal Holloway University of London.

Her work focuses mainly on cognitive aspects of multiple sclerosis (MS). She is Co-Chair of the Brief International Cognitive Assessment for MS initiative (www.BICAMS.net), which has 30 countries in the international validation pipeline (of whom 16 have published to date) and has been recommended by the American Academy of Neurology. Her other research interests include Benefits and Risks of MS Medication (BRIMMS), an evidence-based protocol that presents information about disease modifying drugs in a way that increases the understanding of people with MS; developing the Motor Planning Index, a measure of cerebellar function for MS; how young people with MS use health information websites; and how cognition relates to the employment experience of people with MS. She has been neuropsychology lead on many international trials of MS medication and natural history, for pharma. She is Co-Chair of MS in the 21st Century, a group of people with MS and health professionals who publish papers, collect data and develop tools to improve MS healthcare (www.msinthe21stcentury.com). She is a Trustee of the UK MS Trust (www.mstrust.org) and author of their online cognition tool for people with MS (www.stayingsmart.org). She is a Fellow of the British Psychological Society and an Honorary Professor in the Preventative Neurology Unit within the Wolfson Institute, Queen Mary University of London.